Skip to main content
PMC home page
Trials logoLink to Trials
. 2019 Jan 14;20:48. doi: 10.1186/s13063-018-3155-9

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

David S Lawrence 1,2,✉, Nabila Youssouf 1,2, Síle F Molloy 3, Alexandre Alanio 4, Melanie Alufandika 5, David R Boulware 6,7, Timothée Boyer-Chammard 4, Tao Chen 8, Francoise Dromer 4, Admire Hlupeni 9, William Hope 10, Mina C Hosseinipour 11, Cecilia Kanyama 11, Oliver Lortholary 4, Angela Loyse 3, David B Meya 6, Mosepele Mosepele 2,12, Conrad Muzoora 6, Henry C Mwandumba 5,8, Chiratidzo E Ndhlovu 9, Louis Niessen 8, Charlotte Schutz 13, Katharine E Stott 5,10, Duolao Wang 8, David G Lalloo 8, Graeme Meintjes 13, Shabbar Jaffar 8, Thomas S Harrison 3, Joseph N Jarvis 1,2
PMCID: PMC6332521  PMID: 30642386

Correction to: Trials (2018) 19:649

https://doi.org/10.1186/s13063-018-3026-4

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.

  • Originally published name:

    Sile L F Molloy

  • Correct name:

    Sile F Molloy

Reference

  • 1.Lawrence DS, et al. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial. Trials. 2018;19:649. doi: 10.1186/s13063-018-3026-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Trials are provided here courtesy of BMC

RESOURCES